DEVLX
Price
$71.29
Change
+$0.42 (+0.59%)
Updated
Sep 11 closing price
Net Assets
3.29B
VSCAX
Price
$31.44
Change
+$0.20 (+0.64%)
Updated
Sep 11 closing price
Net Assets
11.18B
Interact to see
Advertisement

DEVLX vs VSCAX

DEVLX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
VS
DEVLX vs. VSCAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEVLX is a Hold and VSCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 11.2B vs. DEVLX (3.29B). DEVLX pays higher dividends than VSCAX: DEVLX (1.07) vs VSCAX (0.21). DEVLX was incepted earlier than VSCAX: DEVLX (39 years) vs VSCAX (27 years). VSCAX (1.10) and DEVLX (1.09) have similar cost to investors . VSCAX is a more actively managed with annual turnover of: 79.00 vs. DEVLX (21.00). DEVLX (6%) and VSCAX (6%) have equivalent initial investment costs. DEVLX (1000) and VSCAX (1000) have matching initial minimum investment requirements. VSCAX annual gain was more profitable for investors over the last year : 21.35 vs. DEVLX (5.00). VSCAX return over 5 years is better than : 60.95 vs. DEVLX (3.00).
DEVLXVSCAXDEVLX / VSCAX
Total Expense Ratio1.091.1099%
Annual Report Gross Expense Ratio1.091.1099%
Fund Existence39 years27 years-
Gain YTD16.63923.42971%
Front Load6%6%105%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.29B11.2B29%
Annual Yield % from dividends1.070.21521%
Returns for 1 year5.0021.3523%
Returns for 3 years14.0062.9422%
Returns for 5 years3.0060.955%
Returns for 10 years48.7194.5252%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLFS34.950.03
+0.09%
BioLife Solutions
BRKR53.43-0.13
-0.24%
Bruker Corp
MNSBP25.08-0.14
-0.54%
MainStreet Bancshares
PACK3.95-0.03
-0.75%
Ranpak Holdings Corp
PAVM4.18-0.09
-2.11%
PAVmed Inc